PinkDx
PrivateLast Round
Series A
Extension
Jan 23, 2025
Total Funding Raised
$50M
Company Overview
PinkDx is a biotechnology company that develops non-invasive molecular diagnostic tests for the early detection of gynecological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PinkDx Comparables
Compare PinkDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MiMARK Diagnostics | 82% | |
| Sola Diagnostics GmbH | 77% | |
| Hera Biotech | 74% |
PinkDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 23, 2025 | ||||
| Series A | Apr 25, 2024 |
Key People
Founding team and executive leadership
PinkDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Production Board | Series A Extension, Series A |
| BEVC | Series A, Series A Extension |
| Catalio Capital Management | Series A, Series A Extension |
| Byers Capital | Series A Extension, Series A |
| Mountain Group Partners | Series A, Series A Extension |
| Blue Venture Fund | Series A, Series A Extension |
| Sandbox Industries | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 100% MoM, reaching 2.2K.
- Apr 16, 2026
Grew 19% QoQ, from 31 to 37 employees.
PinkDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PinkDx's valuation, stock price, and market status.
Is PinkDx a public or private company?
PinkDx is a private company.
What is the current stock price of PinkDx?
PinkDx is a private company, so its shares have no public market price. Caplight tracks PinkDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PinkDx worth (valuation)?
Valuation information for PinkDx is not publicly available.
Can I buy PinkDx stock?
PinkDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PinkDx's last funding round?
PinkDx's most recent funding round was Series A Extension on January 23, 2025.
Who are the main investors in PinkDx?
Key investors in PinkDx include The Production Board, Catalio Capital Management, Mountain Group Partners.
Will PinkDx IPO soon?
No public IPO plans have been announced for PinkDx.
How can I track PinkDx secondary market activity?
Caplight tracks bids, offers, and trades in PinkDx's shares on secondary markets.